BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia-Reference-Cited by-同舟云学术

BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia

Published:2020-08-28 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Fiorcari Stefania,Maffei Rossana,Vallerini Daniela,Scarfò Lydia,Barozzi Patrizia,Maccaferri Monica,Potenza Leonardo,Ghia Paolo,Luppi Mario,Marasca Roberto

Funder

Associazione Italiana per la Ricerca sul Cancro

Fondazione Umberto Veronesi

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis.;Dagenais;Clin Microbiol Rev.,2009

2. Macrophages inhibit Aspergillus fumigatus germination and neutrophil-mediated fungal killing.;Rosowski;PLoS Pathog.,2018

3. Aspergillus fumigatus morphology and dynamic host interactions.;van de Veerdonk;Nat Rev Microbiol.,2017

4. Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies.;Teh;Blood Rev.,2018

5. Tumor-induced host immunosuppression: special focus on CLL.;Cutucache;Int Immunopharmacol.,2013

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors;Critical Reviews in Oncology/Hematology;2024-09

2. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08

3. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

4. Clinical Mycology Today: Emerging Challenges and Opportunities;Open Forum Infectious Diseases;2024-06-27

5. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24